Robot-assisted retroperitoneal lymphadenectomy in patient with type I papillary renal cancer recurrence after 5 years of follow-up.


Journal

Journal of surgical case reports
ISSN: 2042-8812
Titre abrégé: J Surg Case Rep
Pays: England
ID NLM: 101560169

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 09 07 2020
accepted: 29 07 2020
entrez: 19 10 2020
pubmed: 20 10 2020
medline: 20 10 2020
Statut: epublish

Résumé

Papillary renal cell carcinoma (PRCC) is a rare cancer and is the second most frequent histologic type among all renal cell carcinoma, accounting for up to 15%. A 72-year-old man underwent a right radical nephrectomy 7 years ago with final histopathology diagnosis of type 1 PRCC with negative surgical margins. Five years after surgery, computed tomography scan imaging showed the presence of multiple masses suspicious for node recurrences disease localized in the renal lodge, in the inter-aorto-caval space, at the iliac vessels bifurcation and right common iliac vessels. Patient underwent a robotic retroperitoneal lymphadenectomy. The histopathological examination confirmed the recurrence of type I papillary renal cancer in all the specimens. No further recurrences have been observed at 24-month follow-up after surgery. This report is the first describing a robot-assisted minimally invasive surgical excision for type I papillary renal cancer nodal and renal fossa recurrences.

Identifiants

pubmed: 33072251
doi: 10.1093/jscr/rjaa336
pii: rjaa336
pmc: PMC7546679
doi:

Types de publication

Case Reports

Langues

eng

Pagination

rjaa336

Informations de copyright

Published by Oxford University Press and JSCR Publishing Ltd. All rights reserved. © The Author(s) 2020.

Références

Pathol Res Pract. 2001;197(10):671-5
pubmed: 11700888
Cancer. 2008 Apr 1;112(7):1480-8
pubmed: 18240184
Am J Clin Pathol. 1999 Apr;111(4):539-43
pubmed: 10191776
Eur Urol. 2015 Jan;67(1):85-97
pubmed: 24857407
Clin Cancer Res. 2009 Feb 15;15(4):1162-9
pubmed: 19228721
Eur J Cancer. 2012 Oct;48(15):2347-52
pubmed: 22698386
World J Urol. 2016 May;34(5):687-93
pubmed: 26407582
Urology. 2007 Feb;69(2):230-5
pubmed: 17275070
PLoS One. 2013 May 03;8(5):e63341
pubmed: 23658823
J Urol. 2012 Aug;188(2):391-7
pubmed: 22698625

Auteurs

Yazan Al Salhi (Y)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Urology Unit ICOT, Latina, Italy.

Andrea Fuschi (A)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Urology Unit ICOT, Latina, Italy.

Gennaro Velotti (G)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Urology Unit ICOT, Latina, Italy.

Lorenzo Capone (L)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Urology Unit ICOT, Latina, Italy.

Sara Aversa (S)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Pathology Unit ICOT, Latina, Italy.

Cosimo de Nunzio (C)

Department of Urology, La Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.

Natale Porta (N)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Pathology Unit ICOT, Latina, Italy.

Vincenzo Petrozza (V)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Pathology Unit ICOT, Latina, Italy.

Antonio Carbone (A)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Urology Unit ICOT, Latina, Italy.

Antonio Luigi Pastore (AL)

Department of Medico-Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Urology Unit ICOT, Latina, Italy.

Classifications MeSH